Promoter hypermethylation in circulating blood cells identifies prostate cancer progression-Reference-Cited by-同舟云学术

Promoter hypermethylation in circulating blood cells identifies prostate cancer progression

Published:2007 Issue:4 Volume:122 Page:952-956
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Rouprêt Morgan,Hupertan Vincent,Catto James W.F.,Yates David R.,Rehman Ishtiaq,Proctor Laura M.,Phillips Joshua,Meuth Mark,Cussenot Olivier,Hamdy Freddie C.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Cancer Statistics, 2006

2. Prostate Cancer

3. Applicability of biomarkers in the early diagnosis of prostate cancer

4. THE PROSTATE SPECIFIC ANTIGEN ERA IN THE UNITED STATES IS OVER FOR PROSTATE CANCER: WHAT HAPPENED IN THE LAST 20 YEARS?

5. Digital Rectal Exam Following Prostatectomy: Is It Still Necessary with the Use of PSA?

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers;Frontiers in Oncology;2024-09-10

2. Molecular Mechanisms of Prostate Cancer Development in the Precision Medicine Era: A Comprehensive Review;Cancers;2024-01-25

3. Glutathione-S-Transferase $p 1$ Gene Promoter Methylation in Cell-Free DNA as a Diagnostic and Prognostic Tool for Prostate Cancer: A Systematic Review and Meta-Analysis;International Journal of Endocrinology;2023-01-28

4. Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges;British Journal of Cancer;2022-06-17

5. Epigenetics in prostate cancer: clinical implications;Translational Andrology and Urology;2021-07